Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Preventing Lymphedema in Patients Undergoing Axillary Lymph Node Dissection Via Axillary Reverse Mapping and Lympho-venous Bypass

NCT03428581 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT03428581
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03428581 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Preventing Lymphedema in Patients Undergoing Axillary Lymph Node Dissection Via Axillary Reverse Mapping and Lympho-venous Bypass
Lead sponsor
Mayo Clinic
Phase
Not applicable
Overall status
Terminated
Start date
April 10, 2018
Completion date
July 11, 2025
Enrollment
264 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, lymphedema, melanoma